MRA Advisory Group’s Boston Scientific BSX Stock Holding History

MRA Advisory Group’s Portfolio BSX Stock Details BSX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q4	–	Sell	-2,547	Closed	-$249K	–	137
2025 Q3	$249K	Buy	2,547 +2	+0.1%	+$207	0.11%	108
2025 Q2	$273K	Buy	+2,545	New	+$258K	0.13%	104

Other funds holding BSX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Norges Bank Oslo, Norway $935B AUM

MRA Advisory Group's BSX Position: Q4 2025 in Review

MRA Advisory Group sold out of Boston Scientific (BSX) in Q4 2025, closing a stake of 2,547 shares — an estimated $249K sold.

MRA Advisory Group first reported a position in BSX in Q2 2025 and held it in 2 quarters. The position peaked at $273K in Q2 2025. 1,783 funds tracked by Wall St. Rank hold BSX as of Q4 2025.

MRA Advisory Group reported no remaining Boston Scientific position as of Q4 2025 after selling out during the quarter.
MRA Advisory Group sold 2,547 Boston Scientific shares in Q4 2025, an estimated $249K.
MRA Advisory Group first reported a position in Boston Scientific in Q2 2025 and held it in 2 quarters.
MRA Advisory Group's Boston Scientific position peaked at $273K in Q2 2025.
1,783 funds tracked by Wall St. Rank held Boston Scientific as of Q4 2025.

Based on MRA Advisory Group's 13F filing for Q4 2025, filed 16 Jan 2026.